SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001469709-18-000185
Filing Date
2018-11-13
Accepted
2018-11-13 17:09:49
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 AGGX 10-Q 09/30/18 aggx10q_093018apg.htm 10-Q 446767
2 GRAPHIC aggx10q_093018apg002.gif GRAPHIC 178977
3 EXHIBIT 31.1 ex31_1apg.htm EX-31.1 8588
4 EXHIBIT 31.2 ex31_2apg.htm EX-31.2 8659
5 EXHIBIT 32.1 ex32_1apg.htm EX-32.1 3702
6 EXHIBIT 32.2 ex32_2apg.htm EX-32.2 3810
  Complete submission text file 0001469709-18-000185.txt   1836634

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE aggx-20180930.xml EX-101.INS 162620
8 XBRL SCHEMA FILE aggx-20180930.xsd EX-101.SCH 32895
9 XBRL CALCULATION FILE aggx-20180930_cal.xml EX-101.CAL 29680
10 XBRL DEFINITION FILE aggx-20180930_def.xml EX-101.DEF 30980
11 XBRL LABEL FILE aggx-20180930_lab.xml EX-101.LAB 155533
12 XBRL PRESENTATION FILE aggx-20180930_pre.xml EX-101.PRE 123641
Mailing Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017
Business Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017 212-874-6608
AngioGenex, Inc. (Filer) CIK: 0001085596 (see all company filings)

IRS No.: 860945116 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26181 | Film No.: 181179017
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1